Machine learning liver-injuring drug interactions with non-steroidal anti-inflammatory drugs (NSAIDs) from a retrospective electronic health record (EHR) cohort
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Machine learning liver-injuring drug interactions with non-steroidal anti-inflammatory drugs (NSAIDs) from a retrospective electronic health record (EHR) cohort
Authors
Keywords
Drug interactions, Medical risk factors, NSAIDs, Drug dependence, Drug-drug interactions, Drug administration, Adverse reactions, Electronic medical records
Journal
PLoS Computational Biology
Volume 17, Issue 7, Pages e1009053
Publisher
Public Library of Science (PLoS)
Online
2021-07-07
DOI
10.1371/journal.pcbi.1009053
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Extended multi‐item gamma Poisson shrinker methods based on the zero‐inflated Poisson model for postmarket drug safety surveillance
- (2020) Seok‐Jae Heo et al. STATISTICS IN MEDICINE
- Recent Advances in Hepatotoxicity of Non Steroidal Anti-Inflammatory Drugs
- (2018) Lucy Meunier et al. Annals of Hepatology
- Modeling polypharmacy side effects with graph convolutional networks
- (2018) Marinka Zitnik et al. BIOINFORMATICS
- The epidemiology of multimorbidity in primary care: a retrospective cohort study
- (2018) Anna Cassell et al. BRITISH JOURNAL OF GENERAL PRACTICE
- Deep learning improves prediction of drug–drug and drug–food interactions
- (2018) Jae Yong Ryu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CISNE: An accurate description of dose-effect and synergism in combination therapies
- (2018) Amador García-Fuente et al. Scientific Reports
- Searching Synergistic Dose Combinations for Anticancer Drugs
- (2018) Zuojing Yin et al. Frontiers in Pharmacology
- Columbia Open Health Data, clinical concept prevalence and co-occurrence from electronic health records
- (2018) Casey N. Ta et al. Scientific Data
- Topiramate-induced acute liver injury: A rare adverse effect
- (2017) Mangala Rao et al. INDIAN JOURNAL OF PHARMACOLOGY
- Combination therapy in combating cancer
- (2017) Reza Bayat Mokhtari et al. Oncotarget
- What is polypharmacy? A systematic review of definitions
- (2017) Nashwa Masnoon et al. BMC Geriatrics
- Systematic review with network meta-analysis: comparative effectiveness and safety of strategies for preventing NSAID-associated gastrointestinal toxicity
- (2016) J. Q. Yuan et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans
- (2016) Minjun Chen et al. DRUG DISCOVERY TODAY
- Topiramate-Induced Acute Liver Failure in a Pediatric Patient
- (2016) Margaret Z. Tsien et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Changes in Prescription and Over-the-Counter Medication and Dietary Supplement Use Among Older Adults in the United States, 2005 vs 2011
- (2016) Dima M. Qato et al. JAMA Internal Medicine
- A survey of current trends in computational drug repositioning
- (2015) Jiao Li et al. BRIEFINGS IN BIOINFORMATICS
- Feasibility of Prioritizing Drug–Drug-Event Associations Found in Electronic Health Records
- (2015) Juan M. Banda et al. DRUG SAFETY
- Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study
- (2015) Naga Chalasani et al. GASTROENTEROLOGY
- Improving Detection of Arrhythmia Drug-Drug Interactions in Pharmacovigilance Data through the Implementation of Similarity-Based Modeling
- (2015) Santiago Vilar et al. PLoS One
- Systems biology approaches for advancing the discovery of effective drug combinations
- (2015) Karen A Ryall et al. Journal of Cheminformatics
- Drug-Induced Liver Injury
- (2014) Michael D. Leise et al. MAYO CLINIC PROCEEDINGS
- Performance of Pharmacovigilance Signal-Detection Algorithms for the FDA Adverse Event Reporting System
- (2013) R Harpaz et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Mechanisms of Drug-induced Liver Injury
- (2013) Liyun Yuan et al. Clinics in Liver Disease
- Multimorbidity in Older Adults
- (2013) M. E. Salive EPIDEMIOLOGIC REVIEWS
- Use of Non-Steroidal Anti-Inflammatory Drugs That Elevate Cardiovascular Risk: An Examination of Sales and Essential Medicines Lists in Low-, Middle-, and High-Income Countries
- (2013) Patricia McGettigan et al. PLOS MEDICINE
- Data-Driven Prediction of Drug Effects and Interactions
- (2012) N. P. Tatonetti et al. Science Translational Medicine
- Chapter 13: Mining Electronic Health Records in the Genomics Era
- (2012) Joshua C. Denny PLoS Computational Biology
- Clinical and Histopathologic Features of Fluoroquinolone-Induced Liver Injury
- (2011) Eric S. Orman et al. Clinical Gastroenterology and Hepatology
- Assessment of nonsteroidal anti-inflammatory drug-induced hepatotoxicity
- (2011) José AG Agúndez et al. Expert Opinion on Drug Metabolism & Toxicology
- Unrecognized acetaminophen toxicity as a cause of indeterminate acute liver failure
- (2010) Niraj Khandelwal et al. HEPATOLOGY
- Deleterious Effects of Reactive Metabolites
- (2010) Sabry M. Attia Oxidative Medicine and Cellular Longevity
- Non-steroidal anti-inflammatory drugs: What is the actual risk of liver damage?
- (2010) Fernando Bessone WORLD JOURNAL OF GASTROENTEROLOGY
- Synergistic drug combinations tend to improve therapeutically relevant selectivity
- (2009) Joseph Lehár et al. NATURE BIOTECHNOLOGY
- In Vitro Evaluation of Reversible and Irreversible Cytochrome P450 Inhibition: Current Status on Methodologies and their Utility for Predicting Drug–Drug Interactions
- (2008) Stephen Fowler et al. AAPS Journal
- Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United States
- (2008) Naga Chalasani et al. GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More